Modified human hepatitis c virus genomic rna having autonomous replicative competence
It is intended to provide a modified hepatitis C virus genomic RNA having a base sequence containing the 5'-nontranslated region, core protein-encoding sequence, E1 protein-encoding sequence, p7 protein-encoding sequence, E2 protein-encoding sequence, NS2 protein-encoding sequence, NS3 protein-...
Gespeichert in:
1. Verfasser: | |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | It is intended to provide a modified hepatitis C virus genomic RNA having a base sequence containing the 5'-nontranslated region, core protein-encoding sequence, E1 protein-encoding sequence, p7 protein-encoding sequence, E2 protein-encoding sequence, NS2 protein-encoding sequence, NS3 protein-encoding sequence, NS4A protein-encoding sequence, NS4B protein-encoding sequence, NS5A protein-encoding sequence, NS5B protein-encoding sequence and 3'-nontransalated region of two or more hepatitis C virus genomic RNAs and having autonomous replicative competence. In particular, a modified hepatitis C virus genomic RNA which has acquired the autonomous replicative competence via the substitution of a partial RNA sequence encoding NS3 to NS4, NS5A and NS5B proteins in a hepatitis C virus genomic RNA by the partial RNA sequence encoding NS3 to NS4, NS5A and NS5B proteins of JFH1 strain represented by SEQ ID NO:1. |
---|